• Blog
  • Tyrosine Protein Kinase Fyn Market Report

    Tyrosine Protein Kinase Fyn Market Report

    Tyrosine Protein Kinase Fyn Market Report
    Report code - SRHL240 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Tyrosine Protein Kinase Fyn Market, Dynamics, Market Analysis
    See more...

    Impact of COVID-19 on Tyrosine Protein Kinase Fyn Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Tyrosine Protein Kinase Fyn Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Tyrosine Protein Kinase Fyn Market is expected to grow from USD xx million in 2020 to USD xx million by 2026 at a CAGR of over xx % during the forecast period.

    Figure: Global Tyrosine Protein Kinase Fyn Market Size, 2020-2026 (USD Million)

    Tyrosine-Protein-Kinase-Fyn-Market-Forecast

    Wish to get a sample report for free? Click here.

    What is Tyrosine kinase?

    Tyrosine kinase is defined as an enzyme that can transfer a phosphate group from adenosine triphosphate (ATP) to tyrosine residues of specific proteins inside a cell. Tyrosine kinases play a crucial role in many biological processes such as cell adhesion, integrin-mediated signaling, regulation of cell growth and survival, immune response, and cell motility among others.

    Key Players

    Key players operating in the global Tyrosine Protein Kinase Fyn Market are-

    • AB Science SA (France),
    • Bristol-Myers Squibb Co (The U.S),
    • ValiRx Plc (UK),
    • AstraZeneca Plc (UK),
    • Zen-Bio Inc (The U.S),
    • Merck KGaA (Germany),
    • Biocompare, Inc. (The U.S),
    • BioLegend, Inc. (The U.S),
    • Thermo Fisher Scientific (The U.S), and
    • Takara Bio Inc. (Japan).

    Market Dynamics

    The growth of the global tyrosine-protein kinase Fyn market is primarily driven by an increasing number of people suffering from cancer across geographies.

    • Cancer has become the leading cause of death worldwide.
    • According to the International Agency for Research on Cancer, in 2018, around 18.1 million new cases of cancer were diagnosed globally, and this number is likely to increase to around 29.5 million by end of 2040.
    • Thus, increasing cancer cases is likely to propel market growth at a significant rate during the review.
    • Additionally, ongoing research to treat Alzheimer's disease using kinase inhibitors is likely to create lucrative opportunities for the market players.

    Segment Analysis

    Application Trends

    Based on application, the market has been segmented into Alzheimer’s disease, alcohol addiction, breast cancer, cancer pain, and others.

    The cancer pain segment accounted for the largest market share in 2020 owing to the increasing number of people suffering from cancer disease. The Alzheimer's disease segment is projected to register healthy growth during the review period.

    Regional Trends

    Geographically, the market in North America accounted for the largest market share of more than 30% in 2020.

    • The market growth can be attributed to presence of large number of people suffering from cancer and advancement in healthcare solutions.
    • In US, around 18 lakh new cancer cases were diagnosed.
    • The market in Asia-Pacific is expected to increase at a healthy CAGR during the review period on account of increasing demand for advanced healthcare solutions to treat cancer and other diseases.

    COVID-19 Impact on Global Tyrosine Protein Kinase Fyn Market

    The covid-19 outbreak did affect the growth of the Tyrosine-protein kinase Fyn market as many healthcare services were postponed due to a rapid surge in covid-19 cases and a lack of skilled healthcare professionals. Only essential medicals services were allowed amid pandemics and thus, postponement of therapeutic medications affected the market growth for a short period of time.

    Critical Questions Answered in the Report

    • What are the key trends in the global tyrosine protein kinase fyn market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global tyrosine protein kinase fyn market?
    • What are the key strategies adopted by the major vendors to lead in the global tyrosine protein kinase fyn market?
    • What is the market share of the top vendors?

    Want to know the full scope of the report? Register Here

    Target Audience

    Here is the list of the group of customers that the Global Tyrosine Protein Kinase Fyn market hopes to have the greatest opportunity to convert-

    • Tyrosine protein kinase fyn manufacturers
    • Tyrosine protein kinase fyn suppliers
    • Tyrosine protein kinase fyn distributors
    • Organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    AB Science SA (France), Bristol-Myers Squibb Co (The U.S), ValiRx Plc (UK), AstraZeneca Plc (UK), Zen-Bio Inc (The U.S), Merck KGaA (Germany), Biocompare, Inc. (The U.S), BioLegend, Inc. (The U.S), Thermo Fisher Scientific (The U.S) and Takara Bio Inc. (Japan) are among the key players in the tyrosine protein kinase fyn market.

    North America accounted for the largest share of tyrosine protein kinase fyn market in 2020.

    The cancer pain segment accounted for the largest share of tyrosine protein kinase fyn market in 2020.

    Increasing number of people suffering from cancer across geographies, increasing cancer cases, ongoing research to treat Alzheimer's disease using kinase inhibitors are the factors driving the growth of tyrosine protein kinase fyn market.

    Tyrosine protein kinase fyn manufacturers, Tyrosine protein kinase fyn suppliers, Tyrosine protein kinase fyn distributors, Organizations, Government bodies are the target audience in the tyrosine protein kinase fyn market.

    •